Niyati U Mehta1, Victor Grijalva1, Susan Hama1, Alan Wagner1, Mohamad Navab1, Alan M Fogelman1, Srinivasa T Reddy2. 1. From the Department of Molecular and Medical Pharmacology (N.U.M., S.T.R.) and Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles (N.U.M., V.G., S.H., A.W., M.N., A.M.F., S.T.R.). 2. From the Department of Molecular and Medical Pharmacology (N.U.M., S.T.R.) and Division of Cardiology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles (N.U.M., V.G., S.H., A.W., M.N., A.M.F., S.T.R.). sreddy@mednet.ucla.edu.
Abstract
OBJECTIVE: We previously reported that hemopexin (Hx), a heme scavenger, is significantly increased and associated with proinflammatory high-density lipoprotein under atherogenic conditions. Although it is established that Hx together with macrophages plays a role in mitigating oxidative damage, the role of Hx in the development of atherosclerosis is unknown. APPROACH AND RESULTS: We used Hx and apoE double-knockout mice (HxE(-/-)) to determine the role of Hx in the development of atherosclerosis. HxE(-/-) mice had significantly more free heme, reactive oxygen species, and proinflammatory high-density lipoprotein in their circulation, when compared with control apoE(-/-) mice. Atherosclerotic plaque area (apoE(-/-)=9.72±2.5×10(4) μm(2) and HxE(-/-)=27.23±3.6×10(4) μm(2)) and macrophage infiltration (apoE(-/-)=38.8±5.8×10(3) μm(2) and HxE(-/-)=103.4±17.8×10(3) μm(2)) in the aortic sinus were significantly higher in the HxE(-/-) mice. Atherosclerotic lesions in the aortas were significantly higher in the HxE(-/-) mice compared with apoE(-/-) mice. Analysis of polarization revealed that macrophages from HxE(-/-) mice were more M1-like. Ex vivo studies demonstrated that HxE(-/-) macrophage cholesterol efflux capacity was significantly reduced when compared with apoE(-/-) mice. Injection of human Hx into HxE(-/-) mice reduced circulating heme levels and human Hx pretreatment of naive bone marrow cells ex vivo resulted in a shift from M1- to M2-like macrophages. CONCLUSIONS: We conclude that Hx plays a novel protective role in alleviating heme-induced oxidative stress, improving inflammatory properties of high-density lipoprotein, macrophage phenotype and function, and inhibiting the development of atherosclerosis in apoE(-/-) mice.
OBJECTIVE: We previously reported that hemopexin (Hx), a heme scavenger, is significantly increased and associated with proinflammatory high-density lipoprotein under atherogenic conditions. Although it is established that Hx together with macrophages plays a role in mitigating oxidative damage, the role of Hx in the development of atherosclerosis is unknown. APPROACH AND RESULTS: We used Hx and apoE double-knockout mice (HxE(-/-)) to determine the role of Hx in the development of atherosclerosis. HxE(-/-) mice had significantly more free heme, reactive oxygen species, and proinflammatory high-density lipoprotein in their circulation, when compared with control apoE(-/-) mice. Atherosclerotic plaque area (apoE(-/-)=9.72±2.5×10(4) μm(2) and HxE(-/-)=27.23±3.6×10(4) μm(2)) and macrophage infiltration (apoE(-/-)=38.8±5.8×10(3) μm(2) and HxE(-/-)=103.4±17.8×10(3) μm(2)) in the aortic sinus were significantly higher in the HxE(-/-) mice. Atherosclerotic lesions in the aortas were significantly higher in the HxE(-/-) mice compared with apoE(-/-) mice. Analysis of polarization revealed that macrophages from HxE(-/-) mice were more M1-like. Ex vivo studies demonstrated that HxE(-/-) macrophage cholesterol efflux capacity was significantly reduced when compared with apoE(-/-) mice. Injection of humanHx into HxE(-/-) mice reduced circulating heme levels and humanHx pretreatment of naive bone marrow cells ex vivo resulted in a shift from M1- to M2-like macrophages. CONCLUSIONS: We conclude that Hx plays a novel protective role in alleviating heme-induced oxidative stress, improving inflammatory properties of high-density lipoprotein, macrophage phenotype and function, and inhibiting the development of atherosclerosis in apoE(-/-) mice.
Authors: J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf Journal: Science Date: 2000-09-01 Impact factor: 47.728
Authors: Rabea Asleh; Rachael Miller-Lotan; Michael Aviram; Tony Hayek; Michael Yulish; Joanne E Levy; Benjamin Miller; Shany Blum; Uzi Milman; Chen Shapira; Andrew P Levy Journal: Circ Res Date: 2006-11-02 Impact factor: 17.367
Authors: H A Lawson; M Zayed; J P Wayhart; E Fabbrini; L Love-Gregory; S Klein; C F Semenkovich Journal: Int J Obes (Lond) Date: 2017-01-25 Impact factor: 5.095
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Francesca Vinchi; Richard Sparla; Sara T Passos; Richa Sharma; S Zebulon Vance; Hala S Zreid; Hesham Juaidi; Deepa Manwani; Karina Yazdanbakhsh; Vijay Nandi; André M N Silva; Anand R Agarvas; Eitan Fibach; John D Belcher; Gregory M Vercellotti; Husam Ghoti; Martina U Muckenthaler Journal: Br J Haematol Date: 2021-03-15 Impact factor: 6.998
Authors: Natasha A Winter; Peter G Gibson; Michael Fricker; Jodie L Simpson; Peter A Wark; Vanessa M McDonald Journal: Allergy Asthma Immunol Res Date: 2021-05 Impact factor: 5.764
Authors: Louise D McCullough; Mehwish A Mirza; Yan Xu; Kathryn Bentivegna; Eleanor B Steffens; Rodney Ritzel; Fudong Liu Journal: Aging (Albany NY) Date: 2016-07 Impact factor: 5.682